Projecten

Projecten per jaar 1994 1996 1997 1998 1999 2001 2002 2005 2006 2008 2012

• 1 Actief
• 25 Afgelopen

Projecten per jaar

Zoekresultaten

• Actief

  PRIBI56: Exploration of the memory enhancing effects of angiotensin IV and unravelling its mechanism of action.

  Michotte, Y. & Vauquelin, G.

  11/12/07 → …

  Project: Fundamenteel

  • Angiotensin IV 100%
  • angiotensins 92%
• Afgelopen

  FWOAL432: Interactie van neuroleptica met D2-receptoren in intacte cellen.

  Vauquelin, G. & Vanderheyden, P.

  1/01/08 → 31/12/10

  Project: Fundamenteel

  • Antipsychotic Agents 100%
  • CHO Cells 36%
  • Drug Inverse Agonism 15%
  • Drug Partial Agonism 13%
  • apoaequorin 11%

• GOA61: The role of angiotensin IV and identification of its targets.

  Vanderheyden, P., Vauquelin, G., Kooijman, R., Michotte, Y., Sarre, S., Smolders, I., Stragier, B. & Dupont, A.

  1/01/08 → 31/12/12

  Project: Fundamenteel

  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 100%
  • Aminopeptidases 76%
  • Postal Service 62%
  • Insulin 35%
  • Memory 10%

• OZR1347: Opvangmandaat IWT-beurs (toekenning van een OZR-mandaat) tbv Ann Packeu.

  Vauquelin, G.

  1/02/06 → 31/12/06

  Project: Fundamenteel

• FWOAL358: Karakterisering van Cystinyl aminopeptidase (EC .11.3) met nieuw ontwikkelde angiotensine IV analogen.

  Vanderheyden, P., Tourwe, D. & Vauquelin, G.

  1/01/06 → 31/12/09

  Project: Fundamenteel

  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 100%
  • LVV-hemorphin-7 10%
  • Enzymes 8%
  • Aminopeptidases 7%
  • Oxytocin 5%

• OZR1210: Karakterisering van Cystinyl aminopeptidase (EC 3.4.11.3) met nieuw ontwikkelde angiotensine IV analogen.

  Vauquelin, G.

  1/01/06 → 31/12/06

  Project: Fundamenteel

• PRIBI43: In vitro and in vivo studies on the role of the IRAP enzyme/AT4 receptor system in learning and memory processes.

  Vanderheyden, P., Lanckmans, K., Michotte, Y., Smolders, I., Vauquelin, G. & De Bundel, D.

  1/03/05 → 28/02/08

  Project: Fundamenteel

  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 97%
  • Aminopeptidases 90%
  • Angiotensin IV 69%
  • Insulin 46%
  • CD13 Antigens 39%

• IWT256: Moleculaire aangrijpingspunten van Angiotensine IV.

  Demaegdt, H. & Vauquelin, G.

  1/01/05 → 30/09/08

  Project: Fundamenteel

  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 100%
  • Cystinyl Aminopeptidase 98%
  • cystinyl aminopeptidase 51%
  • Type 2 Diabetes Mellitus 44%
  • Pregnancy 35%

• GOA26: Cellular targets for Ang IV: a molecular and pharmaceutical study

  De Bundel, D., Ebinger, G., Van Liefde, I., Demaegdt, H., Vanderheyden, P., Abarca, C., De Backer, J., Michotte, Y., Sarre, S., Smolders, I., Fouyn, R., Vauquelin, G., Stragier, B., Dupont, A. & Le Minh, T.

  1/01/03 → 31/12/07

  Project: Fundamenteel

  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 100%
  • Aminopeptidases 35%
  • Angiotensin IV 26%
  • Ion Pair Liquid Chromatography 23%
  • CD13 Antigens 23%

• OZR733: Farmacologische studie van angiotensine (1-7) bindingssites in doelwitcellen van het renine-angiotensine systeem

  Vauquelin, G.

  1/01/02 → 31/12/03

  Project: Fundamenteel

  • angiotensin I (1-7) 100%
  • Renin-Angiotensin System 59%
  • Pharmacology 30%
  • Angiotensin II 16%
  • des-Asp(1)-des-Arg(2)-Ile(5)-angiotensin II 9%

• DWTC121: G proteïne-gekoppelde receptoren : functionele genoomanalyse, moleculaire farmacologie, structuur-functie studies.

  Vanderheyden, P., De Backer, J., Demaegdt, H., Vauquelin, G. & Le Minh, T.

  1/01/02 → 31/12/06

  Project: Fundamenteel

  • Molecular Structure 100%
  • Genomics 83%
  • G-Protein-Coupled Receptors 83%
  • Pharmacology 55%
  • Aequorin 42%

• FWOAL166: Antagonist-AT 1 receptor interacties : opheldering van een nieuw moleculair mechanisme.

  Le Minh, T., Vanderheyden, P., Fierens, F., Vauquelin, G. & De Backer, J.

  1/01/01 → 31/12/06

  Project: Fundamenteel

  • candesartan 100%
  • Inositol Phosphates 90%
  • CHO Cells 85%
  • Rabbits 50%
  • In Vitro Techniques 31%

• OZR583: Vergelijkend 'in vitro' en in 'vivo' farmakologische studie van AT1 receptor antagonisten.

  Vauquelin, G.

  1/01/01 → 31/12/02

  Project: Fundamenteel

  • Renin-Angiotensin System 100%
  • Pharmacology 96%
  • Angiotensin II 93%
  • In Vitro Techniques 63%
  • CHO Cells 57%

• OZR450: Antagonist- angiotensin II receptor interacties in getransfecteerde cellen.

  Vauquelin, G.

  1/01/00 → 31/12/01

  Project: Fundamenteel

  • Angiotensin Receptor Antagonists 100%
  • CHO Cells 70%
  • Angiotensin Receptors 36%
  • Mutagenesis 29%
  • Anti-Idiotypic Antibodies 24%

• IWT98: Onderzoek naar het farmacologisch en fysiologisch onderscheid van AT1 receptor antagonisten.

  Vauquelin, G.

  1/10/99 → 30/09/03

  Project: Fundamenteel

  • Angiotensin II 100%
  • Renin-Angiotensin System 35%
  • Oral Administration 29%
  • Homeostasis 25%
  • Pharmacology 22%

• FWOAL105: Fysiologische en biochemische karakterisering van receptoren en bindingseiwitten voor insecten-neuropeptiden die behoren tot de tachykinine- en NPY/NPF families.

  Vauquelin, G.

  1/01/99 → 31/12/02

  Project: Fundamenteel

  • Tachykinins 100%
  • Insecta 77%
  • Neuropeptides 75%
  • Carrier Proteins 62%
  • neuropeptides 53%

• OZR382: Fysiologische en farmacologische eigenschappen van angiotensin II receptoren in getransfecteerde cellen.

  Vauquelin, G.

  1/01/99 → 31/12/99

  Project: Fundamenteel

  • Angiotensin Receptors 100%
  • CHO Cells 73%
  • Pharmacology 67%
  • Phosphatidylinositol 4,5-Diphosphate 31%
  • Volition 26%

• FWOAL78: Liganden voor nieuwe bloeddruk-regulerende receptoren uit medicinale planten : screening en structuur -activiteitsrelatie onderzoek.

  Vauquelin, G.

  1/01/98 → 31/12/01

  Project: Fundamenteel

• OZR231: Farmacologische karakterisatie van imidazoline receptoren in hersenweefsel en cellijnen van de mens.

  Ebinger, G., Vauquelin, G. & Flamez, A.

  1/01/98 → 31/12/99

  Project: Fundamenteel

  • Imidazoline Receptors 100%
  • Pharmacology 48%
  • Central Nervous System 38%
  • Cell Line 36%
  • Antihypertensive Agents 19%

• OZR203: Neuropeptide Y: interaktie met receptoren en bindenden proteinen.

  Vauquelin, G.

  1/01/98 → 22/04/99

  Project: Fundamenteel

  • Neuropeptide Y 100%
  • Carrier Proteins 42%
  • Neuropeptide Y Receptors 32%
  • Conotoxins 11%
  • Peptides 9%

• 2973210060: Neuropeptide Y : interaktie met receptoren en bindende proteinen.

  Vauquelin, G.

  1/01/97 → 31/12/99

  Project: Fundamenteel

• DWTC13: Molecular genetics and pathology of signal transduction

  Vauquelin, G.

  1/01/97 → 31/12/01

  Project: Fundamenteel

  • molecular genetics 100%
  • signal transduction 89%
  • Imidazoline Receptors 54%
  • Conotoxins 53%
  • Neuropeptide Y Receptors 50%

• OZR39: Farmacologische karakterisatie van imidazoline receptoren in post-mortem menselijk hersenweefsel en andere species.

  Vauquelin, G. & Flamez, A.

  1/01/97 → 31/12/97

  Project: Fundamenteel

  • Imidazolines 100%
  • Pharmacology 43%
  • Brain 32%
  • Binding Sites 25%

• 2933210050: Serotonine bindende proteinen : distributie in hersen regio's en perifere weefsels, identiteit en betrokkenheid bij pathologische mechanismen.

  Vauquelin, G.

  1/01/96 → 31/12/97

  Project: Fundamenteel

• FWOAL20477: Toepassingen van electrospray massaspectrometrie in moleculair biologisch onderzoek.

  Hernalsteens, J., Van Driessche, E., Vauquelin, G. & Wyns, L.

  1/01/96 → 31/12/99

  Project: Fundamenteel

  • mass spectrometry 100%
  • liquid chromatography 39%
  • ligands 35%
  • protein phosphorylation 21%
  • post-translational modification 20%

• FGWAL20151: Serotonine bindende proteinen : distributie in hersen regio's en perifere weefsels, identiteit en betrokkenheid bij pathologische mechanismen .

  Vauquelin, G.

  1/01/94 → 31/12/97

  Project: Fundamenteel

  • serotonin-binding protein 100%
  • Brain 23%
  • Catecholamines 22%
  • Serotonin 20%
  • Oxidopamine 14%